JP2020513404A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513404A5 JP2020513404A5 JP2019529476A JP2019529476A JP2020513404A5 JP 2020513404 A5 JP2020513404 A5 JP 2020513404A5 JP 2019529476 A JP2019529476 A JP 2019529476A JP 2019529476 A JP2019529476 A JP 2019529476A JP 2020513404 A5 JP2020513404 A5 JP 2020513404A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antagonist
- amino acid
- acid sequence
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022132878A JP7351989B2 (ja) | 2016-12-01 | 2022-08-24 | 炎症性状態の処置方法 |
| JP2023148026A JP2023175785A (ja) | 2016-12-01 | 2023-09-13 | 炎症性状態の処置方法 |
| JP2025167062A JP2026016421A (ja) | 2016-12-01 | 2025-10-03 | 炎症性状態の処置方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662428634P | 2016-12-01 | 2016-12-01 | |
| US62/428,634 | 2016-12-01 | ||
| US201762473738P | 2017-03-20 | 2017-03-20 | |
| US62/473,738 | 2017-03-20 | ||
| US201762567318P | 2017-10-03 | 2017-10-03 | |
| US62/567,318 | 2017-10-03 | ||
| PCT/US2017/064041 WO2018102597A1 (en) | 2016-12-01 | 2017-11-30 | Methods of treating inflammatory conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022132878A Division JP7351989B2 (ja) | 2016-12-01 | 2022-08-24 | 炎症性状態の処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513404A JP2020513404A (ja) | 2020-05-14 |
| JP2020513404A5 true JP2020513404A5 (https=) | 2021-01-07 |
| JP7132220B2 JP7132220B2 (ja) | 2022-09-06 |
Family
ID=60788696
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019529476A Active JP7132220B2 (ja) | 2016-12-01 | 2017-11-30 | 炎症性状態の処置方法 |
| JP2022132878A Active JP7351989B2 (ja) | 2016-12-01 | 2022-08-24 | 炎症性状態の処置方法 |
| JP2023148026A Pending JP2023175785A (ja) | 2016-12-01 | 2023-09-13 | 炎症性状態の処置方法 |
| JP2025167062A Pending JP2026016421A (ja) | 2016-12-01 | 2025-10-03 | 炎症性状態の処置方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022132878A Active JP7351989B2 (ja) | 2016-12-01 | 2022-08-24 | 炎症性状態の処置方法 |
| JP2023148026A Pending JP2023175785A (ja) | 2016-12-01 | 2023-09-13 | 炎症性状態の処置方法 |
| JP2025167062A Pending JP2026016421A (ja) | 2016-12-01 | 2025-10-03 | 炎症性状態の処置方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US10815305B2 (https=) |
| EP (1) | EP3548513A1 (https=) |
| JP (4) | JP7132220B2 (https=) |
| KR (3) | KR102780485B1 (https=) |
| CN (2) | CN110167963B (https=) |
| AU (2) | AU2017367691B2 (https=) |
| BR (1) | BR112019010646A2 (https=) |
| CA (1) | CA3044851A1 (https=) |
| CL (1) | CL2019001475A1 (https=) |
| CO (1) | CO2019005236A2 (https=) |
| CR (1) | CR20190311A (https=) |
| IL (1) | IL266770B2 (https=) |
| MA (1) | MA46954A (https=) |
| MX (2) | MX2019006177A (https=) |
| MY (1) | MY200433A (https=) |
| NZ (2) | NZ794842A (https=) |
| PH (1) | PH12019501120A1 (https=) |
| TN (1) | TN2019000172A1 (https=) |
| TW (2) | TWI857389B (https=) |
| UA (1) | UA127965C2 (https=) |
| WO (1) | WO2018102597A1 (https=) |
| ZA (1) | ZA201903091B (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6306588B2 (ja) | 2012-08-21 | 2018-04-04 | サノフィ・バイオテクノロジー | Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法 |
| KR102460040B1 (ko) | 2016-04-27 | 2022-11-01 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| TWI857389B (zh) | 2016-12-01 | 2024-10-01 | 美商再生元醫藥公司 | 治療發炎症狀的方法 |
| WO2018156180A1 (en) | 2017-02-24 | 2018-08-30 | Kindred Biosciences, Inc. | Anti-il31 antibodies for veterinary use |
| ES3052989T3 (en) | 2017-04-13 | 2026-01-16 | Regeneron Pharma | Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding il33 and il1rl1 |
| CA3066918A1 (en) | 2017-06-12 | 2018-12-20 | Bluefin Biomedicine, Inc. | Anti-il1rap antibodies and antibody drug conjugates |
| KR102694419B1 (ko) * | 2017-10-30 | 2024-08-09 | 사노피 바이오테크놀로지 | Il-4r 길항제를 투여하여 천식을 치료 또는 예방하는 방법 |
| JP2021508719A (ja) | 2017-12-29 | 2021-03-11 | コーネル・ユニバーシティーＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ | 好酸球性障害のための遺伝子療法 |
| JP6835292B2 (ja) | 2018-04-10 | 2021-02-24 | 昭和電工マテリアルズ株式会社 | エポキシ樹脂、エポキシ樹脂組成物、エポキシ樹脂硬化物及び複合材料 |
| IL307286B2 (en) | 2018-04-11 | 2026-03-01 | Regeneron Pharma | Methods and reagents for IL-33 quantification |
| US11312778B2 (en) | 2018-11-21 | 2022-04-26 | Brian C. Machler | Method for treating allergic contact dermatitis |
| CN110746507B (zh) | 2018-12-25 | 2020-06-26 | 江苏荃信生物医药有限公司 | 抗人白介素4受体α单克隆抗体及其应用 |
| EP3911369A4 (en) | 2019-01-18 | 2022-11-16 | Orthobio Therapeutics, Inc. | EDITING GENES TO IMPROVE JOINT FUNCTION |
| TW202519263A (zh) * | 2019-03-21 | 2025-05-16 | 美商再生元醫藥公司 | 含有抗il-33抗體之穩定調配物 |
| SG11202111255YA (en) * | 2019-05-01 | 2021-11-29 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-33 antagonist |
| WO2021011614A1 (en) | 2019-07-16 | 2021-01-21 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4r antagonist |
| US20230101029A1 (en) * | 2019-10-11 | 2023-03-30 | General Regeneratives (Shanghai) Limited | Methods of using il-33 protein in treating cancers |
| AU2020380588A1 (en) * | 2019-11-04 | 2022-06-09 | Medimmune Limited | Anti IL-33 therapeutic agent FPR treating renal disorders |
| BR112022010934A2 (pt) * | 2019-12-06 | 2022-11-29 | Sanofi Biotechnology | Métodos para tratar copd administrando um antagonista de il-33 |
| EP4081544A1 (en) * | 2019-12-23 | 2022-11-02 | Sanofi Biotechnology | Methods for treating or preventing allergic asthma by administering an il-33 antagonist and/or an il-4r antagonist |
| JP2023516497A (ja) | 2020-03-13 | 2023-04-19 | メドイミューン・リミテッド | Ｉｌ３３にリスクアレルを有する対象を治療するための治療方法 |
| US20230174637A1 (en) * | 2020-04-06 | 2023-06-08 | Medimmune Limited | Treating acute respiratory distress syndrome with il-33 axis binding antagonists |
| CN113527485B (zh) * | 2020-04-17 | 2024-11-15 | 湖南麦济生物技术股份有限公司 | 抗人白细胞介素-4受体α抗体及其制备方法和应用 |
| CN113549151A (zh) * | 2020-04-24 | 2021-10-26 | 苏州康乃德生物医药有限公司 | 与人IL-4Rα中特定表位结合的抗体及其应用 |
| JP7578943B2 (ja) * | 2020-07-13 | 2024-11-07 | 学校法人自治医科大学 | 褥瘡治療剤 |
| CN111714619B (zh) * | 2020-07-15 | 2023-03-14 | 上海市浦东新区人民医院 | 成纤维生长因子6在制备缓解非酒精性脂肪性肝炎肝损伤的药物中的应用 |
| KR20230123993A (ko) * | 2020-12-23 | 2023-08-24 | 누맙 세러퓨틱스 아게 | Il-31에 결합하는 항체 가변 도메인 |
| CN117858898A (zh) * | 2021-08-27 | 2024-04-09 | 免疫医疗有限公司 | 用抗白介素-33抗体治疗慢性阻塞性肺病 |
| MX2024005769A (es) * | 2021-11-11 | 2024-05-24 | Regeneron Pharma | Tratamiento de la enfermedad pulmonar basado en la estratificacion de puntuacion de riesgo poligenico para la interleucina 33 (il-33). |
| WO2024095849A1 (ja) | 2022-10-31 | 2024-05-10 | トヨタ自動車株式会社 | 車両制御システム、車両製造方法、プログラム及び情報処理装置 |
| AU2024227899A1 (en) * | 2023-02-28 | 2025-09-04 | Kodiak Sciences Inc. | Multivalent trap-antibody fusions |
| CN120118185B (zh) * | 2025-03-11 | 2025-08-26 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 一种猫过敏原Fel d 1蛋白单克隆抗体及其应用 |
Family Cites Families (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| GB8808015D0 (en) | 1988-04-06 | 1988-05-05 | Ritter M A | Chemical compounds |
| WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
| JPH06510750A (ja) | 1991-05-03 | 1994-12-01 | セラジェン インク | 炎症性関節炎治療を目的としてインタ−ロイキン受容体を標的にした分子 |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US5714146A (en) | 1992-08-26 | 1998-02-03 | Board Of Regents Of The University Of Washington | IL-4 bone therapy |
| EP0604693A1 (en) | 1992-12-29 | 1994-07-06 | Schering-Plough | Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same |
| RU2162711C2 (ru) | 1993-09-07 | 2001-02-10 | Смитклайн Бичам Корпорейшн | Рекомбинантные il4-антитела, используемые для лечения нарушений, связанных с действием il4 |
| US5576191A (en) | 1994-06-17 | 1996-11-19 | Immunex Corporation | Cytokine that binds ST2 |
| WO2000016804A1 (en) | 1998-09-18 | 2000-03-30 | Dynavax Technologies Corporation | METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN |
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6323334B1 (en) | 1999-09-24 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding a 103 gene product and uses therefor |
| EP2990420B1 (en) | 2000-05-26 | 2016-12-21 | Immunex Corporation | Use of interleukin-4 receptor antibodies and compositions thereof |
| US7879328B2 (en) | 2000-06-16 | 2011-02-01 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator |
| US20030103938A1 (en) | 2001-05-09 | 2003-06-05 | Alk-Abello A/S | Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio |
| US20050031609A1 (en) | 2001-05-11 | 2005-02-10 | Thomas Hultsch | Compositions for use in treating ige-associated disorders |
| DK1450855T3 (da) | 2001-05-23 | 2010-01-11 | Duotol Ab | Undertrykkelse af allergiske reaktioner ved hjælp af transdermal indgivelse af allergener i forbindelse med eller konjugeret til toxin-underenheder eller fragmenter deraf |
| ES2327830T3 (es) | 2002-03-29 | 2009-11-04 | Schering Corporation | Anticuerpos monoclonales humanos anti-interleuquina-5 y metodos y composiciones que los contienen. |
| WO2004056868A2 (en) | 2002-12-19 | 2004-07-08 | Endocube Sas | Nf-hev compositions and methods of use |
| SI2000481T1 (sl) | 2003-02-01 | 2016-08-31 | Tanox, Inc. | Anti-humana protitelesa IgE z visoko afiniteto |
| US7923209B2 (en) | 2003-03-14 | 2011-04-12 | Anergis, S.A. | Allergen peptide fragments and use thereof |
| MXPA06004853A (es) | 2003-11-07 | 2006-07-06 | Immunex Corp | Anticuerpos que se aglutinan al receptor 4 de interleucina. |
| CA2550933A1 (en) | 2003-12-22 | 2005-07-14 | Amgen Inc. | Methods for identifying functional antibodies |
| NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
| AU2005219837A1 (en) | 2004-02-27 | 2005-09-15 | Regeneron Pharmaceuticals, Inc. | IL-4/IL-13 sepecific polypetides and therapeutic uses thereof |
| US20090098142A1 (en) | 2004-06-09 | 2009-04-16 | Kasaian Marion T | Methods and compositions for treating and monitoring treatment of IL-13-associated disorders |
| TWI307630B (en) | 2004-07-01 | 2009-03-21 | Glaxo Group Ltd | Immunoglobulins |
| US8030003B2 (en) | 2004-12-07 | 2011-10-04 | Children's Hospital Medical Center | Diagnosis of eosinophilic esophagitis based on presence of an elevated level of eotaxin-3 |
| TW200902555A (en) | 2005-01-03 | 2009-01-16 | Hoffmann La Roche | Antibodies against IL-13 receptor alpha 1 and uses thereof |
| CN102321174B (zh) | 2005-05-06 | 2013-10-16 | 津莫吉尼蒂克斯公司 | Il-31单克隆抗体及使用方法 |
| US7666622B2 (en) | 2005-10-19 | 2010-02-23 | Regeneron Pharmaceuticals, Inc. | Monomeric self-associating fusion polypeptides and therapeutic uses thereof |
| US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| WO2007140205A2 (en) | 2006-05-24 | 2007-12-06 | Biogen Idec Ma Inc. | Methods of treating fibrosis |
| ES2398076T3 (es) | 2006-06-02 | 2013-03-13 | Regeneron Pharmaceuticals, Inc. | Anticuerpos de alta afinidad contra el receptor de IL-6 humano |
| US7560530B1 (en) | 2006-07-20 | 2009-07-14 | Schering Corporation | IL-33 receptor |
| JP4221018B2 (ja) | 2006-08-31 | 2009-02-12 | トヨタ自動車株式会社 | 頭部保護エアバッグ装置 |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| CN101522716B (zh) | 2006-10-02 | 2013-03-20 | 瑞泽恩制药公司 | 抗人il-4受体的高亲和力人抗体 |
| IE20080331A1 (en) | 2007-04-26 | 2009-07-08 | Trinity College Dublin | Products for altering cytokine activity and methods therefor |
| AU2008254704A1 (en) | 2007-05-18 | 2008-11-27 | Medimmune, Llc | IL-33 in inflammatory disease |
| EP2022507A1 (en) | 2007-08-07 | 2009-02-11 | Universität Hamburg | Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy |
| US7982016B2 (en) | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| JP2011500748A (ja) | 2007-10-26 | 2011-01-06 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 神経変性障害の治療におけるｃａｓｐａｓｅＩ−依存性サイトカインの阻害剤 |
| US8637239B2 (en) | 2007-11-05 | 2014-01-28 | The Board Of Trustees Of The University Of Illinois | Minimally-invasive measurement of esophageal inflammation |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| DE202008006598U1 (de) | 2008-04-11 | 2008-10-02 | Alk-Abelló A/S | Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung |
| US20090264392A1 (en) | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
| EP2376656A4 (en) | 2008-12-01 | 2012-05-16 | Cincinnati Children S Hospital Medical Ct | METHOD AND DETERMINATION OF THE EFFECTIVENESS OF A GLUCOCORTICOID TREATMENT OF EOSINOPHILIAN ESOPHAGITIS |
| US8497528B2 (en) | 2010-05-06 | 2013-07-30 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method for fabricating a strained structure |
| CN102596237A (zh) | 2009-09-07 | 2012-07-18 | Dbv技术公司 | 治疗嗜酸细胞性食管炎的方法 |
| WO2011031600A1 (en) | 2009-09-10 | 2011-03-17 | Schering Corporation | Use of il-33 antagonists to treat fibrotic disease |
| US20120164080A1 (en) | 2010-06-24 | 2012-06-28 | Meritage Pharma, Inc. | Methods of treatment for esophageal inflammation |
| BR112013008366B1 (pt) | 2010-10-06 | 2022-02-08 | Regeneron Pharmaceuticals, Inc | Formulações farmacêuticas líquidas estáveis contendo anticorpos anti-receptor de interleucina-4 humana alfa, e recipiente contendo as referidas formulações |
| WO2012094643A2 (en) | 2011-01-06 | 2012-07-12 | Children's Hospital Medical Center | Esophageal cytokine expression profiles in eosinophilic esophagitis |
| WO2012113813A1 (en) | 2011-02-23 | 2012-08-30 | F. Hoffmann-La Roche Ag | Antibodies against human il33r and uses thereof |
| EP2723899B1 (en) | 2011-06-21 | 2020-11-18 | Children's Hospital Medical Center | Diagnostic methods for eosinophilic esophagitis |
| CN103974706A (zh) | 2011-10-06 | 2014-08-06 | N·V·努特里奇亚 | 嗜酸细胞性食管炎的治疗 |
| WO2013155010A1 (en) | 2012-04-09 | 2013-10-17 | Children's Hospital Medical Center | Non-invasive biomarkers for eosinophilic esophagitis |
| US9090694B2 (en) | 2012-04-30 | 2015-07-28 | Janssen Biotech, Inc. | ST2L antibody antagonists |
| AR091069A1 (es) | 2012-05-18 | 2014-12-30 | Amgen Inc | Proteinas de union a antigeno dirigidas contra el receptor st2 |
| JP6306588B2 (ja) * | 2012-08-21 | 2018-04-04 | サノフィ・バイオテクノロジー | Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法 |
| PL2892927T3 (pl) | 2012-09-07 | 2018-11-30 | Regeneron Pharmaceuticals, Inc. | Sposoby leczenia atopowego zapalenia skóry przez podawanie antagonisty IL-4R |
| US10132809B2 (en) | 2012-10-10 | 2018-11-20 | Rhote Island Hospital | Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis |
| JO3532B1 (ar) * | 2013-03-13 | 2020-07-05 | Regeneron Pharma | الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها |
| WO2014152195A1 (en) * | 2013-03-15 | 2014-09-25 | Regeneron Pharmaceuticals, Inc. | Il-33 antagonists and uses thereof |
| TWI755763B (zh) | 2013-06-04 | 2022-02-21 | 美商再生元醫藥公司 | 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法 |
| AU2014284235C1 (en) * | 2013-06-21 | 2025-07-31 | Regeneron Pharmaceuticals, Inc. | Methods for treating nasal polyposis by administering an IL-4R antagonist |
| TWI634900B (zh) | 2013-07-11 | 2018-09-11 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| BR112016013347B1 (pt) | 2013-12-26 | 2023-12-12 | Mitsubishi Tanabe Pharma Corporation | Anticorpo monoclonal humano neutralizante anti-il-33, composição farmacêutica, inibidor da expressão de citocinas, molécula de ácido nucleico, vetor, célula bacteriana transgênica, método de produção e uso dos mesmos |
| SG11201605580RA (en) | 2014-01-10 | 2016-10-28 | Anaptysbio Inc | Antibodies directed against interleukin-33 (il-33) |
| IL315136A (en) * | 2014-02-21 | 2024-10-01 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4rantagonist |
| KR102695088B1 (ko) | 2014-02-28 | 2024-08-16 | 리제너론 파아마슈티컬스, 인크. | Ｉｌ-4ｒ 길항제의 투여에 의한 피부 감염의 치료 방법 |
| NO2785538T3 (https=) * | 2014-05-07 | 2018-08-04 | ||
| TWI705976B (zh) | 2014-11-10 | 2020-10-01 | 美商建南德克公司 | 抗介白素-33抗體及其用途 |
| CN107109494B (zh) | 2014-11-10 | 2023-10-27 | 豪夫迈·罗氏有限公司 | Il-33介导型疾病的治疗方法和诊断方法 |
| KR102261618B1 (ko) | 2015-03-31 | 2021-06-04 | 메디뮨 리미티드 | 신규한 il33 형태, il33의 돌연변이된 형태, 항체, 검정 및 이의 이용 방법 |
| TWI857389B (zh) | 2016-12-01 | 2024-10-01 | 美商再生元醫藥公司 | 治療發炎症狀的方法 |
-
2017
- 2017-11-29 TW TW111142355A patent/TWI857389B/zh active
- 2017-11-29 TW TW106141530A patent/TWI784988B/zh active
- 2017-11-30 CN CN201780073449.2A patent/CN110167963B/zh active Active
- 2017-11-30 MA MA046954A patent/MA46954A/fr unknown
- 2017-11-30 JP JP2019529476A patent/JP7132220B2/ja active Active
- 2017-11-30 NZ NZ794842A patent/NZ794842A/en unknown
- 2017-11-30 AU AU2017367691A patent/AU2017367691B2/en active Active
- 2017-11-30 BR BR112019010646A patent/BR112019010646A2/pt unknown
- 2017-11-30 KR KR1020247007290A patent/KR102780485B1/ko active Active
- 2017-11-30 MY MYPI2019002952A patent/MY200433A/en unknown
- 2017-11-30 UA UAA201907159A patent/UA127965C2/uk unknown
- 2017-11-30 KR KR1020197015123A patent/KR102645242B1/ko active Active
- 2017-11-30 EP EP17818689.6A patent/EP3548513A1/en active Pending
- 2017-11-30 TN TNP/2019/000172A patent/TN2019000172A1/en unknown
- 2017-11-30 CA CA3044851A patent/CA3044851A1/en active Pending
- 2017-11-30 CN CN202410698813.6A patent/CN118662629A/zh active Pending
- 2017-11-30 CR CR20190311A patent/CR20190311A/es unknown
- 2017-11-30 IL IL266770A patent/IL266770B2/en unknown
- 2017-11-30 NZ NZ754300A patent/NZ754300A/en unknown
- 2017-11-30 US US15/827,357 patent/US10815305B2/en active Active
- 2017-11-30 MX MX2019006177A patent/MX2019006177A/es unknown
- 2017-11-30 KR KR1020257007692A patent/KR20250040088A/ko active Pending
- 2017-11-30 WO PCT/US2017/064041 patent/WO2018102597A1/en not_active Ceased
-
2019
- 2019-05-17 ZA ZA2019/03091A patent/ZA201903091B/en unknown
- 2019-05-20 PH PH12019501120A patent/PH12019501120A1/en unknown
- 2019-05-22 CO CONC2019/0005236A patent/CO2019005236A2/es unknown
- 2019-05-28 MX MX2023008368A patent/MX2023008368A/es unknown
- 2019-05-30 CL CL2019001475A patent/CL2019001475A1/es unknown
-
2020
- 2020-09-22 US US17/028,011 patent/US11866503B2/en active Active
-
2022
- 2022-08-24 JP JP2022132878A patent/JP7351989B2/ja active Active
-
2023
- 2023-09-13 JP JP2023148026A patent/JP2023175785A/ja active Pending
- 2023-11-29 US US18/523,048 patent/US20240209102A1/en active Pending
-
2024
- 2024-12-10 AU AU2024278257A patent/AU2024278257A1/en active Pending
-
2025
- 2025-10-03 JP JP2025167062A patent/JP2026016421A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020513404A5 (https=) | ||
| JP2018533557A5 (https=) | ||
| JP7454882B2 (ja) | 抗ヒトインターロイキン－４受容体α抗体及びその調製方法並びに使用 | |
| KR102307248B1 (ko) | Il-4r 길항제의 투여에 의한 천식의 치료 또는 예방 방법 | |
| CN110167963A (zh) | 治疗发炎病况的方法 | |
| JP2016513644A5 (https=) | ||
| EP2627673B1 (en) | Therapies for improving pulmonary function | |
| JP2019531273A5 (https=) | ||
| Grainge et al. | Targeted therapeutics for severe refractory asthma: monoclonal antibodies | |
| JP2019534282A (ja) | 抗ｉｌ−３３抗体およびその使用 | |
| RU2009120202A (ru) | Способы и композиции для лечения и мониторинга лечения связанных с il-13 расстройств | |
| JPWO2018191479A5 (https=) | ||
| RU2016134838A (ru) | Дипептидил пептидаза-4 (dpp4/cd26) как периферический биомаркер активации il-13 в астматическом легком | |
| JP2025122028A (ja) | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 | |
| JP7458790B2 (ja) | Ｉｌ－６阻害剤を含有する喘息の治療剤 | |
| Hartley et al. | Severe asthma: novel advances in the pathogenesis and therapy | |
| CN115151568A (zh) | 用于通过施用il-33拮抗剂和/或il-4r拮抗剂以治疗或预防过敏性哮喘的方法 | |
| TW202317622A (zh) | 以ｓｔ２拮抗劑治療慢性阻塞性肺病的方法 | |
| JP2025164767A (ja) | Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法 | |
| JP6663910B2 (ja) | 抗ＴＮＦ−α抗体療法を受けた乾癬患者を治療するための方法 | |
| US11156600B2 (en) | Assay for detecting TH1 and TH2 cell populations | |
| CN114423455A (zh) | 用于治疗系统性硬化症的药物组合物 | |
| Leung et al. | Emerging treatment options in severe asthma | |
| Seymour et al. | Intervention in Severe Eosinophilic | |
| JP2026068738A (ja) | Ｉｌ－３３アンタゴニストおよび／またはｉｌ－４ｒアンタゴニストを投与することによりアレルギー性喘息を治療するまたは予防するための方法 |